98 related articles for article (PubMed ID: 4298145)
1. [Review. Physiopathology and treatment of urolothiasis].
Fleisch H; Bisaz S
Z Urol Nephrol; 1966 Nov; 59(11):785-800. PubMed ID: 4298145
[No Abstract] [Full Text] [Related]
2. [Studies of phosphate therapy of urinary calculi].
Kollwitz AA; Kracht H; Meier F
Urologe; 1966 Jul; 5(4):168-71. PubMed ID: 4296919
[No Abstract] [Full Text] [Related]
3. [Administration of a diphosphonate in urinary calculi prevention].
Baumann JM; Ganz U; Bisaz S; Fleisch H; Rutishauser G
Helv Chir Acta; 1974 Sep; 41(4):421-4. PubMed ID: 4369478
[No Abstract] [Full Text] [Related]
4. Orthophosphate and other phosphate compounds in relation to stone formation.
Fleisch H
Adv Exp Med Biol; 1978; 103():203-16. PubMed ID: 213950
[No Abstract] [Full Text] [Related]
5. Evaluation of the urinary stone former.
Drach GW
Semin Urol; 1984 Feb; 2(1):12-9. PubMed ID: 6463458
[No Abstract] [Full Text] [Related]
6. [Pyrophosphate levels of the urine in lithiasis].
Sommer-Tsilenis E; Kallistratos G; Timmermann A
Munch Med Wochenschr; 1967 Feb; 109(6):293-5. PubMed ID: 4298874
[No Abstract] [Full Text] [Related]
7. [Significance of mucopolysaccharide elimination in urolithiasis].
Hesse A; Hartmann U; Schneider HJ; Horn G
Z Urol Nephrol; 1975 Jun; 70(6):401-5. PubMed ID: 127480
[No Abstract] [Full Text] [Related]
8. Nomograms for the estimation of the saturation of urine with calcium oxalate, calcium phosphate, magnesium ammonium phosphate, uric acid, sodium acid urate, ammonium acid urate and cystine.
Marshall RW; Robertson WG
Clin Chim Acta; 1976 Oct; 72(2):253-60. PubMed ID: 975580
[No Abstract] [Full Text] [Related]
9. [Prevention of recurrence in urolithiasis].
Terhorst B; Melchior H
Z Urol Nephrol; 1969; 62(10):761-73. PubMed ID: 4326184
[No Abstract] [Full Text] [Related]
10. Orthophosphate treatment in calcium urolithiasis.
Smith LH; Werness PG; VanDenBerg CJ; Wilson DM
Scand J Urol Nephrol Suppl; 1980; 53():253-63. PubMed ID: 6938002
[No Abstract] [Full Text] [Related]
11. [Genesis of urolithiasis].
Schmucki O; Asper R
Ther Umsch; 1980 May; 37(5):336-41. PubMed ID: 7394754
[No Abstract] [Full Text] [Related]
12. Symposium on renal lithiasis. Renal lithiasis in review.
Finlayson B
Urol Clin North Am; 1974 Jun; 1(2):181-212. PubMed ID: 4372765
[No Abstract] [Full Text] [Related]
13. Studies of bladder stone disease in Thailand. X. Effect of orthophosphate and nonfat dry milk supplementations on urine composition.
Valyasevi A; Dhanamitta S; Van Reen R
Am J Clin Nutr; 1969 Feb; 22(2):218-27. PubMed ID: 4304084
[No Abstract] [Full Text] [Related]
14. Management of the stone former.
Burns JR; Finlayson B
Semin Urol; 1984 Feb; 2(1):34-44. PubMed ID: 6463460
[No Abstract] [Full Text] [Related]
15. [Blood amino acids and aminoaciduria in urinary calculosis].
Borgno M; Frea B; Perolino PM; Tizzani A
Minerva Urol; 1974; 26(5):195-202. PubMed ID: 4449538
[No Abstract] [Full Text] [Related]
16. [Action mechanism of orthophosphate in urinary calculi].
Schneider HJ; Wasmund HG
Z Urol Nephrol; 1971 May; 64(5):343-9. PubMed ID: 5142710
[No Abstract] [Full Text] [Related]
17. [The value attached to clinical laboratory findings in urolithiasis (author's transl)].
Zechner O; Höltl G; Zekoff K; Zekert F
Wien Klin Wochenschr; 1974 Nov; 86(21):654-7. PubMed ID: 4428778
[No Abstract] [Full Text] [Related]
18. [Urinary excretion of calcium, magnesium, phosphates, oxalates and urates in normal children en Switzerland].
Matos V; Melle GV; Markert M; Guignard JP
Rev Med Suisse Romande; 1996 Oct; 116(10):839-43. PubMed ID: 8966463
[No Abstract] [Full Text] [Related]
19. [Possibilities of the conservative treatment of urinary calculi in experiment and clinic].
Ubelhör R; Gasser G
Urologe; 1968; 7(1):41-6. PubMed ID: 5654488
[No Abstract] [Full Text] [Related]
20. Studies on bladder stone disease in Thailand. XV. Factors affecting the solubility of calcium oxalate.
Chulkaratana S; Van Reen R; Valyasevi A
Invest Urol; 1971 Nov; 9(3):246-50. PubMed ID: 5137334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
